Keyphrases
9p21
20%
Adenocarcinoma
20%
Adenocarcinoma Cells
20%
Adjuvant Chemotherapy
40%
Am(III)
20%
Chromosomal Instability
20%
Copy number Aberrations
60%
Copy number Analysis
100%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Disease-free Survival
60%
Early-stage Lung Cancer
100%
False Discovery Rate
20%
Gene Copy number
40%
Genome-wide Analysis
20%
Genome-wide Studies
20%
Hazard Ratio
100%
Identified Genes
20%
Lung Cancer-specific Survival
20%
Molecular Inversion Probes
20%
Multicenter Randomized Trial
20%
Non-small Cell Lung Cancer (NSCLC)
40%
Non-small Cell Lung Cancer Patients
20%
Predictive Marker
100%
Prognostic Implications
20%
Prognostic Marker
100%
Resectable Lung Cancer
20%
SNP Assay
20%
Squamous Cell Carcinoma (SqCC)
40%
STK11
20%
Tumor Samples
20%
Medicine and Dentistry
Adenocarcinoma
40%
Adjuvant Chemotherapy
40%
Cancer Specific Survival
20%
Chromosomal Instability
20%
Disease Free Survival
60%
Gene Dosage
40%
Genome Wide Association Study
20%
Hazard Ratio
100%
Lung Cancer
20%
Molecular Inversion Probe
20%
Neoplasm
20%
Non Small Cell Lung Cancer
100%
Predictive Marker
100%
Single Nucleotide Polymorphism
20%
Squamous Cell Carcinoma
40%
Biochemistry, Genetics and Molecular Biology
Cancer Specific Survival
33%
Chromosome Instability
33%
Copy Number Analysis
100%
Disease Free Survival
100%
Gene Dosage
66%
Genome Wide Association Study
33%
Molecular Inversion Probe
33%
Single Nucleotide Polymorphism
33%
STK11
33%
Immunology and Microbiology
Cancer Specific Survival
33%
Chromosomal Instability
33%
Disease Free Survival
100%
Gene Dosage
66%
Single Nucleotide Polymorphism
33%
Squamous Cell
66%
Agricultural and Biological Sciences
Gene Dosage
100%
Single Nucleotide Polymorphism
50%
STK11
50%